There are two Otsuka pharmaceutical industry companies in the U.S.:
Otsuka America Pharmaceutical, Inc. (OAPI) successfully commercializes Otsuka-discovered and in-licensed products in North America.
Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC) clinically develops and registers innovative healthcare products on a global basis.
|
|
|
|
|
1,001-5,000 employees
View all Otsuka Pharmaceutical Companies (U.S.) employees
|
|
|
Pharmaceutical Manufacturing
|
|
|
$1B–$5B
|
|
|
(609) 524-2000
|
|
|
508 Carnegie Center, Princeton, NJ 08540, US
|
|
|
None
|
|
|
Neuroscience
|
Tarek Rabah is the CEO of Otsuka Pharmaceutical Companies (U.S.). To contact Tarek Rabah email at [email protected], [email protected] or [email protected].
The decision makers in Otsuka Pharmaceutical Companies (U.S.) are , Jane Urban, John Sokol, etc. Click to Find Otsuka Pharmaceutical Companies (U.S.) decision makers emails.
Otsuka Pharmaceutical Companies (U.S.) headquarters is located at 508 Carnegie Center, Princeton, NJ 08540, US.
Otsuka Pharmaceutical Companies (U.S.) generates an estimated $1B–$5B annually, based on industry analysis and publicly available market data.
You can contact Otsuka Pharmaceutical Companies (U.S.) by calling (609) 524-2000.
Find accurate personal emails, work emails and phone numbers for employees
Accelerate prospecting with instant access to 350M professionals from 40M companies with the right contact details.